324 related articles for article (PubMed ID: 21968368)
1. Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.
Satlin MJ; Kubin CJ; Blumenthal JS; Cohen AB; Furuya EY; Wilson SJ; Jenkins SG; Calfee DP
Antimicrob Agents Chemother; 2011 Dec; 55(12):5893-9. PubMed ID: 21968368
[TBL] [Abstract][Full Text] [Related]
2. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.
van Duin D; Cober ED; Richter SS; Perez F; Cline M; Kaye KS; Kalayjian RC; Salata RA; Evans SR; Fowler VG; Bonomo RA
Clin Microbiol Infect; 2014 Dec; 20(12):O1117-20. PubMed ID: 24931918
[TBL] [Abstract][Full Text] [Related]
3. Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.
van Duin D; Cober E; Richter SS; Perez F; Kalayjian RC; Salata RA; Evans S; Fowler VG; Kaye KS; Bonomo RA
J Antimicrob Chemother; 2015 Apr; 70(4):1203-11. PubMed ID: 25492391
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.
Dubrovskaya Y; Chen TY; Scipione MR; Esaian D; Phillips MS; Papadopoulos J; Mehta SA
Antimicrob Agents Chemother; 2013 Nov; 57(11):5394-7. PubMed ID: 23959321
[TBL] [Abstract][Full Text] [Related]
5. Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes.
Chiu SK; Chan MC; Huang LY; Lin YT; Lin JC; Lu PL; Siu LK; Chang FY; Yeh KM
PLoS One; 2017; 12(4):e0175140. PubMed ID: 28388651
[TBL] [Abstract][Full Text] [Related]
6. Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.
Mouloudi E; Massa E; Piperidou M; Papadopoulos S; Iosifidis E; Roilides I; Theodoridou T; Kydona C; Fouzas I; Imvrios G; Papanikolaou V; Gritsi-Gerogianni N
Transplant Proc; 2014 Nov; 46(9):3219-21. PubMed ID: 25420864
[TBL] [Abstract][Full Text] [Related]
7. Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.
Jacobs DM; Safir MC; Huang D; Minhaj F; Parker A; Rao GG
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):76. PubMed ID: 29178957
[TBL] [Abstract][Full Text] [Related]
8. [Controlling infection and spread of carbapenems-resistant Klebsiella pneumoniae among burn patients].
Huan J
Zhonghua Shao Shang Za Zhi; 2015 Feb; 31(1):5-8. PubMed ID: 25876631
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.
Lee GC; Burgess DS
Ann Clin Microbiol Antimicrob; 2012 Dec; 11():32. PubMed ID: 23234297
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
Tian Y; Zhang Q; Wen L; Chen J
Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
[TBL] [Abstract][Full Text] [Related]
11. Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae.
van Duin D; Cober E; Richter SS; Perez F; Kalayjian RC; Salata RA; Evans S; Fowler VG; Bonomo RA; Kaye KS
Infect Control Hosp Epidemiol; 2015 Aug; 36(8):942-8. PubMed ID: 25990806
[TBL] [Abstract][Full Text] [Related]
12. [The efficacy and safety of different antimicrobial regimens in carbapenem-resistant
Sun WM; Zhou H; Shen LS; Yang Q; Ma WJ; Zhou JY
Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):566-571. PubMed ID: 31365977
[No Abstract] [Full Text] [Related]
13. Evolution of tigecycline- and colistin-resistant CRKP (carbapenem-resistant Klebsiella pneumoniae) in vivo and its persistence in the GI tract.
Zhang R; Dong N; Huang Y; Zhou H; Xie M; Chan EW; Hu Y; Cai J; Chen S
Emerg Microbes Infect; 2018 Jul; 7(1):127. PubMed ID: 29985412
[TBL] [Abstract][Full Text] [Related]
14. Proteomics Study of the Synergistic Killing of Tigecycline in Combination With Aminoglycosides Against Carbapenem-Resistant
Ma X; Fu S; Wang Y; Zhao L; Yu W; He Y; Ni W; Gao Z
Front Cell Infect Microbiol; 2022; 12():920761. PubMed ID: 35846751
[TBL] [Abstract][Full Text] [Related]
15. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
Zhang R; Cai JC; Zhou HW; Nasu M; Chen GX
J Med Microbiol; 2011 Dec; 60(Pt 12):1813-1819. PubMed ID: 21835972
[TBL] [Abstract][Full Text] [Related]
16. Resistance evolution of hypervirulent carbapenem-resistant
Jin X; Chen Q; Shen F; Jiang Y; Wu X; Hua X; Fu Y; Yu Y
Emerg Microbes Infect; 2021 Dec; 10(1):1129-1136. PubMed ID: 34074225
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria.
Qureshi ZA; Syed A; Clarke LG; Doi Y; Shields RK
Antimicrob Agents Chemother; 2014 Jun; 58(6):3100-4. PubMed ID: 24637691
[TBL] [Abstract][Full Text] [Related]
18. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
RodrÃguez-Avial C; RodrÃguez-Avial I; Merino P; Picazo JJ
Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients.
Pouch SM; Kubin CJ; Satlin MJ; Tsapepas DS; Lee JR; Dube G; Pereira MR
Transpl Infect Dis; 2015 Dec; 17(6):800-9. PubMed ID: 26341757
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.
Huang PH; Chen WY; Chou SH; Wang FD; Lin YT
Microbiol Spectr; 2022 Jun; 10(3):e0038122. PubMed ID: 35652641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
